Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism [Phase 4]
Phase 4 trial update for fluoxetine and bupropion in patients with depression and alcoholism; study terminated with posted results.
-
CLINICAL_TRIALS research · 2021-07-09Clinical Trial Update: Brain Connectivity and Response to Tai Chi in Geriatric Depression [NA]
A completed clinical trial examining brain connectivity and response to Tai Chi in adults with major depressive disorder.
-
FDA approval · 2021-07-07FDA Approved: DESIPRAMINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original application for DESIPRAMINE HYDROCHLORIDE tablets from Alembic Pharmaceuticals Limited. The product is indicated f…
-
FDA approval · 2021-07-06FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
FDA approved a supplemental application for Mirtazapine from Aurolife Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity [NA]
Clinical trial update for a pragmatic trauma care system study addressing PTSD with comorbidity; study completed with posted results in 2021…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-06-30FDA Approved: VENLAFAXINE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original application for venlafaxine from Dr. Reddy's Laboratories, making a generic version of the antidepressant availabl…
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia [NA]
Clinical trial update on cognitive recovery after electroconvulsive therapy and general anesthesia, with completed status and posted results…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Effectiveness and Implementation of Brief Cognitive Behavioral Therapy in CBOCs [NA]
A completed VA study evaluating the effectiveness and implementation of brief cognitive behavioral therapy in community-based outpatient cli…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age [Phase 3]
Phase 3 continuation study of vortioxetine in children and adolescents (7-17) with major depressive disorder has completed.
-
EMA withdrawal · 2021-06-22EMA Withdrawn: Nodetrip (previously Xeristar) (duloxetine) — Esteve Pharmaceuticals, S.A.
The EMA has withdrawn Nodetrip (duloxetine) from Esteve Pharmaceuticals, covering indications in anxiety disorders, major depressive disorde…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Risperidone and Suicidality in Major Depressive Disorder [Phase 3]
Phase 3 clinical trial update on risperidone for suicidality in major depressive disorder completed.
-
FDA approval · 2021-06-10FDA Approved: VENLAFAXINE — Original Application (Ascend Laboratories, LLC)
FDA approved a generic venlafaxine product from Ascend Laboratories, LLC under Original Application (ANDA).
-
FDA approval · 2021-06-07FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride from Sun Pharmaceutical Industries, indicating an updated regulatory…
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms [NA]
Clinical trial update on mindfulness-based cognitive therapy delivered via group videoconferencing for ACS patients with elevated depression…
-
CLINICAL_TRIALS research · 2021-06-04Clinical Trial Update: TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic [Phase 2, Phase 3]
A clinical trial update on transcranial direct current stimulation (TDCS) in pediatric and teenage patients with major depressive disorder d…
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers [Phase 4]
Phase 4 trial update on behavioral activation and varenicline for smoking cessation in depressed smokers; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Programs To Support You During Chemotherapy [NA]
A completed clinical trial sponsored by Wake Forest University Health Sciences focused on providing support during chemotherapy, with result…
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: MemFlex to Prevent Depressive Relapse [Phase 2]
Phase 2 trial update for MemFlex aimed at preventing depressive relapse in adults with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 [Phase 1, Phase 2]
A Phase 1/Phase 2 trial investigating recovery of damaged cells to address post-COVID-19 sequelae and related conditions. Current status is …
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Treating Smokers With Mental Illness [Phase 2]
Phase 2 clinical trial assessing treatments for smoking cessation in individuals with mental illness; study completed with posted results in…
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19 [NA]
A completed clinical trial evaluating scalable, single-session interventions for adolescent depression during the COVID-19 context; results …
-
FDA approval · 2021-05-19FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Amitriptyline hydrochloride as an original-application generic from Unichem Pharmaceuticals (USA), Inc. (ANDA 214548).
-
CLINICAL_TRIALS research · 2021-05-18Clinical Trial Update: The S.M.A.R.T. Project: Stress Management and Resilience Training for Teens [NA]
Clinical trial update for the S.M.A.R.T. Project on stress management and resilience training for teens; study completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Sleep-Disordered Breathing and PAP in Perinatal Depression [NA]
Update on a completed clinical trial evaluating sleep-disordered breathing and positive airway pressure (PAP) in perinatal depression; resul…
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) for Motor Symptoms in Psychiatric Disorders [NA]
Clinical trial update on transcranial magnetic stimulation (TMS) for motor symptoms in psychiatric disorders; study completed with results p…